Symposia: Health Services and Quality—Lymphoid Malignancies
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Biological therapies, Lymphoid Leukemias, ALL, Clinical Practice (Health Services and Quality), Lymphomas, non-Hodgkin lymphoma, epidemiology, elderly, Chimeric Antigen Receptor (CAR)-T Cell Therapies, Plasma Cell Disorders, B Cell lymphoma, Combination therapy, Clinical Research, Diversity, Equity, and Inclusion (DEI) , Diseases, Therapies, aggressive lymphoma, real-world evidence, Lymphoid Malignancies, registries, young adult , Study Population, Human, Minimal Residual Disease
Type: Oral
Hematology Disease Topics & Pathways:
Research, Biological therapies, Lymphoid Leukemias, ALL, Clinical Practice (Health Services and Quality), Lymphomas, non-Hodgkin lymphoma, epidemiology, elderly, Chimeric Antigen Receptor (CAR)-T Cell Therapies, Plasma Cell Disorders, B Cell lymphoma, Combination therapy, Clinical Research, Diversity, Equity, and Inclusion (DEI) , Diseases, Therapies, aggressive lymphoma, real-world evidence, Lymphoid Malignancies, registries, young adult , Study Population, Human, Minimal Residual Disease
Monday, December 12, 2022: 4:30 PM-6:00 PM
La Nouvelle Orleans Ballroom AB
(Ernest N. Morial Convention Center)
Moderators:
Matthew C. Cheung, MD, MSc, Sunnybrook Odette Cancer Centre
and
Amy L Billett, MD, Dana-farber/Boston Children's Cancer and Blood Disorders Ctr
Disclosures:
No relevant conflicts of interest to declare.
4:30 PM
5:00 PM
5:15 PM
5:30 PM
5:45 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH